STAAR Surgical Current Valuation vs. EBITDA
| STAA Stock | USD 26.68 0.05 0.19% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.48 | 0.7751 |
|
|
For STAAR Surgical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of STAAR Surgical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well STAAR Surgical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between STAAR Surgical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of STAAR Surgical over time as well as its relative position and ranking within its peers.
STAAR |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share 0.44 | Revenue Per Share 6.962 | Quarterly Revenue Growth 0.103 | Return On Assets 0.0339 |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
STAAR Surgical EBITDA vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining STAAR Surgical's current stock value. Our valuation model uses many indicators to compare STAAR Surgical value to that of its competitors to determine the firm's financial worth. STAAR Surgical is rated below average in current valuation category among its peers. It is rated below average in ebitda category among its peers totaling about 0.03 of EBITDA per Current Valuation. The ratio of Current Valuation to EBITDA for STAAR Surgical is roughly 33.68 . At present, STAAR Surgical's EBITDA is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the STAAR Surgical's earnings, one of the primary drivers of an investment's value.STAAR Surgical's Earnings Breakdown by Geography
STAAR Current Valuation vs. Competition
STAAR Surgical is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 225.63 Billion. STAAR Surgical adds roughly 1.12 Billion in current valuation claiming only tiny portion of equities under Health Care industry.
STAAR EBITDA vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
STAAR Surgical |
| = | 1.12 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
STAAR Surgical |
| = | 33.22 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
STAAR EBITDA Comparison
STAAR Surgical is currently under evaluation in ebitda category among its peers.
STAAR Surgical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in STAAR Surgical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, STAAR Surgical will eventually generate negative long term returns. The profitability progress is the general direction of STAAR Surgical's change in net profit over the period of time. It can combine multiple indicators of STAAR Surgical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.1 M | -4.3 M | |
| Operating Income | 28.1 M | 29.5 M | |
| Income Before Tax | 33.7 M | 35.4 M | |
| Total Other Income Expense Net | 5.6 M | 5.9 M | |
| Net Income | 21.3 M | 22.4 M | |
| Income Tax Expense | 12.3 M | 13 M | |
| Net Income From Continuing Ops | 21.3 M | 22.4 M | |
| Non Operating Income Net Other | 1.4 M | 1.5 M | |
| Net Income Applicable To Common Shares | 44.6 M | 46.8 M | |
| Interest Income | 214.2 K | 203.5 K | |
| Net Interest Income | 7 M | 7.3 M | |
| Change To Netincome | 24.5 M | 25.7 M | |
| Net Income Per Share | 0.58 | 0.61 | |
| Income Quality | 1.79 | 1.88 | |
| Net Income Per E B T | 0.88 | 1.13 |
STAAR Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on STAAR Surgical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of STAAR Surgical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the STAAR Surgical's important profitability drivers and their relationship over time.
Use STAAR Surgical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STAAR Surgical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STAAR Surgical will appreciate offsetting losses from the drop in the long position's value.STAAR Surgical Pair Trading
STAAR Surgical Pair Trading Analysis
The ability to find closely correlated positions to STAAR Surgical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STAAR Surgical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STAAR Surgical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STAAR Surgical to buy it.
The correlation of STAAR Surgical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STAAR Surgical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STAAR Surgical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STAAR Surgical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your STAAR Surgical position
In addition to having STAAR Surgical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Value Funds Thematic Idea Now
Large Value Funds
Funds or Etfs that invest in the undervalued stocks of large-sized companies. The Large Value Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Value Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
To fully project STAAR Surgical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of STAAR Surgical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include STAAR Surgical's income statement, its balance sheet, and the statement of cash flows.